Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options (Q36912496)

17 August 2017

1 reference

title

Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options (English)

1 reference

17 August 2017

Jan de Lange

1

1 reference

PubMed ID

17703964

17 August 2017

Hans P van den Akker

series ordinal

2

1 reference

PubMed ID

17703964

17 August 2017

Henk van den Berg

series ordinal

3

1 reference

17 August 2017

20 August 2007

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

17 August 2017

1 reference

17 August 2017

104

1 reference

17 August 2017

5

1 reference

17 August 2017

603-615

1 reference

Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granuloma of the jaws: experiences in the management of thirty-seven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The central giant cell reparative granuloma of the jaws. An analysis of 38 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granuloma of jaws--review of 19 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Incidence and disease-free survival after surgical therapy of central giant cell granulomas of the jaw in The Netherlands: 1990-1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell lesions of the jaws. A clinical, radiologic, and histopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granulomas: a systematic review of the radiographic characteristics with the addition of 20 new cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Radiologic features of central giant cell granuloma of the jaws.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granuloma of the jaws: a clinico-radiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Radiographic features of central giant cell granuloma of the jaws in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Clinical and radiological features of central giant-cell lesions of the jaw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell lesions of the jaws: a clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell lesions of the mandible and maxilla: a clinicopathologic and cytometric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Synchronous central giant cell lesions of the jaws: report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Markers for macrophage and osteoclast lineages in giant cell lesions of the oral cavity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Phenotypic characterization of mononuclear and multinucleated cells of giant cell reparative granuloma of small bones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Gene expression of vascular endothelial growth factor in giant cell tumors of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Giant cell granuloma of the jawbones--a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Variant translocations involving 16q22 and 17p13 in solid variant and extraosseous forms of aneurysmal bone cyst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The gene for cherubism maps to chromosome 4p16.3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The gene for cherubism maps to chromosome 4p16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

A Missense Mutation in the SH3BP2 Gene on Chromosome 4p16.3 Found in a Case of Nonfamilial Cherubism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Noonan syndrome associated with central giant cell granuloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Cherubism - new hypotheses on pathogenesis and therapeutic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Interaction of the parathyroid hormone receptor with the 14-3-3 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Regulation of secretion of osteoprotegerin in rat dental follicle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Noonan-like/multiple giant cell lesion syndrome: report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Bilateral central giant cell granulomas in a patient with neurofibromatosis: report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Neurofibromatosis 1: a novel NF1 mutation in an 11-year-old girl with a giant cell granuloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Role of the NF1 gene in leukemogenesis and myeloid growth control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Different mutations in the NF1 gene are associated with Neurofibromatosis–Noonan syndrome (NFNS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Long-term clinical and radiological outcomes of surgical management of central giant cell granuloma of the maxilla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granuloma of the jaws: a clinical, radiologic, and histopathologic study of 26 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The surgical treatment of central giant cell granuloma of the mandible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Local injection of corticosteroids for central giant cell granuloma. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Intralesional corticosteroid injection for central giant cell granuloma. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Treatment of giant cell granuloma of the maxilla with intralesional injection of steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Treatment of a central giant cell lesion of the mandible with intralesional glucocorticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Intralesional corticosteroids as an alternative treatment for central giant cell granuloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Treatment of a central giant cell granuloma with intralesional corticosteroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Intralesional infiltration of corticosteroids in the treatment of localised langerhans' cell histiocytosis of the mandible Report of known cases and three new cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Effect of corticosteroids on human osteoclast formation and activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Estrogen modulation of osteoclast lysosomal enzyme secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Immunohistochemical expression of glucocorticoid and calcitonin receptors as a tool for selecting therapeutic approach in central giant cell granuloma of the jawbones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The multinucleate cells in giant cell granulomas of the jaw are osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Calcitonin Receptors of Human Osteoclastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Calcitonin receptors on neoplastic mononuclear cells cultured from a human giant-cell tumor of the sacrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Central giant cell granulomas of the jaws regress with calcitonin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Treatment of central giant cell granuloma of the jaw with calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Rapid growth of giant cell granuloma in pregnancy treated with calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Calcitonin therapy for central giant cell granuloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Calcitonin therapy in central giant cell granuloma of the jaw: a randomized double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Biomedical technology revolution: opportunities and challenges for oral and maxillofacial surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Effect of interferon-alpha-2b on porcine mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Complications of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The anti-angiogenic basis of metronomic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

The effect of a single dose of osteoprotegerin in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Nuclear factor-kappaB activation: a question of life or death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

Imatinib as a potential antiresorptive therapy for bone disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.04.003

10.1016/J.TRIPLEO.2007.04.003

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17703964